สำนักราชบัณฑิตยสภา

The Journal of the Royal Institute of Thailand Vol. 27 No. 3 Jul.-Sept. 2002 «‘ «— ≤π“°“√¢Õß¡“≈“‡√’ ¬ ¯ÛÙ Òˆ. World Health Organization Resolu- tion WHA 8:30. Off Rec WHO 1955' 63: 31. Ò˜. World Health Organization Resolu- tion WHA 22:39 Off Rec WHO 1969; 176:18 and Annex 13. Ò¯. ª√–¬Ÿ √ °ÿ ≥“»≈. °“√√–∫“¥¢Õß¡“≈“‡√’ ¬ „πª√–‡∑»‰∑¬ ªï ÚıÙÛ, °Õߧ«∫§ÿ ¡ ‚√§µ‘ ¥µà Õ °√–∑√«ß “∏“√≥ ÿ ¢ (µ‘ ¥µà Õ à «πµ— «). Ò˘. Udeinya I, Aikawa H, Schmidt JA, Miller LH, Green I. Falciparum ma- laria infected erythrocytes bind to cultured human endothelial cells. Science 1961; 213: 555-7. Ú. Krishna S. Science, medicine and the future malaria. Br Med J 315: 730-2. ÚÒ. Bruce-Chwatt LJ. Essential malari- ology. 2nd ed. London: William Heinemann Medical Books; 1985. p. 103-26. ÚÚ. Bradley DJ, Newbold CI, Warrell DA. Malaria. In: Weatherall DJ, Ledingham GG, Warrell DA, editors. Oxford textbook of medicine, 2nd ed. Oxford: Oxford Univ Press; 1987. p. 5.474-502. ÚÛ. Schulemann W. Synthetic antima- larial preparations. Proc R Soc Med 1932; 25: 897-905. ÚÙ. µ√–Àπ— °®‘ µ À–√‘ ≥ ÿ µ, ¡‘ §–‡ π S, ¥π— ¬ ∫ÿ ππ“§. Chloroquine resistance plas- modium falciparum in Thailand. UNESCO 1st Regional Symposium on Scientific Knowledge of Tropical parasites Singapore 1962 DC 148-53. Úı. Young MD, Moore DV. Chloroquine resistance in Plasmodium falciparum . Am J Trop Med Hyg 1961; 10: 317- 20. Úˆ. »√™— ¬ À≈Ÿ Õ“√’ ¬å ÿ «√√≥, ¥π— ¬ ∫ÿ ππ“§. ´‘ ß ‡Œ“´Ÿ : ¡ÿ π‰æ√®’ π √— °…“¡“≈“‡√’ ¬. «“√ “√‚√§µ‘ ¥‡™◊È Õ ÚıÚ˘; Û: Ò˘˘- Úˆ. Ú˜. Enea V, Ellis J, Zavala F, et al. DNA cloning of Plasmodium falciparum circumsporozoite gene amino acid sequence of repetitive epitope. Sci- ence 1984; 225: 628-30. Ú¯. Cross AP, Singer B. Modelling the development of resistance of Plas- modium falciparum to antimalarial drugs. Trans R Soc Trop Med Hyg 1991; 85: 349-55. Ú˘. Wellems TE. How chloroquine works. Nature 1992; 355: 108-9. Û. Foote SJ, Galatis D, Cowman AF. Amino acids in the dihydrofolate re- ductase-thymidylate synthease gene of Plasmodium falciparum involved in cycloguanil resistance differ from those in pyrimethamine resistance. Proc Natl Acad Sci USA 1990; 87: 3014-7. ÛÒ. Wilson CM, Serrano AE, Walsey A, Bogenschutz MP, Shankar AH, Wirth DF. Amplificetion of a gene related to mamalian mdr genes in drug-re- sistant Plasmodium falciparum . Sci- ence 1989; 244: 1184-6. ÛÚ. World Health Organization. The role of artemisinin and its derivatives in the current treatment of malaria (1994-1995). Report of an informal consultation convened by WHO in Geneva, 27-29 September 1993; 1- 49. ÛÛ. Brasseur P, Kouamouo J, Brandicourt O, Moyor SR, Druilhe P. Patterns of in vitro resistance to chloroquine, quinine and mefloquine of Plasmo- dium falciparum in Cameroon 1985- 1986. Am J Trop Med Hyg 1988; 39: 166-72. ÛÙ. Warsame M, Wernsdorfer WH, Bjorkman A. Lack of effect of De- sipramine of the response to chloro- quine of patients with chloroguine- resistant falciparum malaria. Trans R Soc Trop Med Hyg 1992; 86: 235- 6. Ûı. White NJ, »√™— ¬ À≈Ÿ Õ“√’ ¬å ÿ «√√≥, Warrell DA, et al. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg 1983; 32: 1-5. Ûˆ. µ√–Àπ— °®‘ µ À–√‘ ≥ ÿ µ, ¥π— ¬ ∫ÿ ππ“§, ÿ π∑√ ¡— ¬ P, «‘ √“«√√≥ C. Chloroquinne resistance in Thailand. Lancet 1965; 2: 657-60. Û˜. µ√–Àπ— °®‘ µ À–√‘ ≥ ÿ µ, ¥π— ¬ ∫ÿ ππ“§. Drug resistant malaria with special reference to chemotherapy. Mosquito Born Dis Ball 1984; : 23-30. Û¯. µ√–Àπ— °®‘ µ À–√‘ ≥ ÿ µ, ¥π— ¬ ∫ÿ ππ“§. Management of malaria special ref- erence to drug resistance. Jpn J Trop Med Hyg 1988; 16: 121-30. Û˘. Nosten F, Ter Kuile, ·∑π ®ß»ÿ ¿™— ¬ ‘ ∑∏‘Ï , et al. Mefloquine resistant falciparum malaria on the Thai Burmese Bordu. Lancet 1991; 337: 1140-3. Ù. Ter Kuile F, Nosten F, Thieren M, et al. High dose Mefloquiene in the treatment of multidrug resistant falciparum Malaria. J Infect Dis 1992; 166: 1363-400. ÙÒ. π‘ ¿“ ®√Ÿ ≠‡« ¡å , µ√–Àπ— °®‘ µ À–√‘ ≥ ÿ µ, ≈“«— ≥¬å ‡¡◊ Õß¡≥’ . Recrudescence poor response or resistance to quinine of falciparum malaria in Thailand. Southeast Asian J Trop Med & Pub Hlth 1974; 5: 504-9. ÙÚ. Watt G, Loesuttivibool L, Shanks GD, et al. Quinine with tetracycline for the treatment of drug resistant falciparum malaria in Thailand. Am J Trop Med Hyg 1992; 47: 108-11. ÙÛ. »√™— ¬ À≈Ÿ Õ“√’ ¬å ÿ «√√≥. æ≈√— µπå «‘ ‰≈√— µπå , «“π‘ ™¬å ™“ππ∑å S, Webster KD. Effi- cacy of quinine tetracycline for acute uncomplicated falciparum malaria in Thailand Lancet. 1992; 339: 369. ÙÙ. ª√’ ™“ ‡®√‘ ≠≈“¿, µ√–Àπ— °®‘ µ À–√‘ ≥ ÿ µ. Relapses of vivax malaria after a con- ventional course of primaquine and chloroquine : report of two cases. Southeast Asian J Trop Med & Publ Hlth. 1973; 4: 135-7. Ùı. ¥π— ¬ ∫ÿ ππ“§, °“∫«— ß J, ∏π«‘ ∫Ÿ ≈¬å A, et al. High dose of primaquine in pri- maquine resistant vivax malaria. Trans R Soc Trop Med Hyg 1994; 88: 218-9. Ùˆ. Tagett GA. Spf 66 a candidate syn- thetic malaria vaccine : Immunoge- nicity versus protection. Parasito- logy Today 1992; 8: 354-5. Ù˜. Sempertegui F, Estrrella S, Mosoco J, et al. Safety, immunogenicity and